Last reviewed · How we verify
Postoperative nausea and vomiting — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Barhemsys | AMISULPRIDE | Acacia | Dopamine-2 Receptor Antagonist [EPC] | D(2) dopamine receptor | 2020-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 3 drugs in Postoperative nausea and vomiting
- Acacia · 1 drug in Postoperative nausea and vomiting
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Postoperative nausea and vomiting:
- Postoperative nausea and vomiting treatment updates — RSS
- Postoperative nausea and vomiting treatment updates — Atom
- Postoperative nausea and vomiting treatment updates — JSON
Cite this brief
Drug Landscape (2026). Postoperative nausea and vomiting — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/postoperative-nausea-and-vomiting. Accessed 2026-06-10.
Related
- Postoperative nausea and vomiting full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing